Hematological Side Effects of Pegylated Interferon/ Ribavirin Therapy   in Chronic HCV Egyptian Patients
Hepatitis C virus (HCV) infection is a major health problem throughout the World. Egypt has the highest worldwide prevalence of HCV (10-20%). The combination of peginterferon and ribavirin can achieve sustained virologic response in over 50% of those treated. However, adherence to treatment is critical to maintain high rates of virologic clearance. Unfortunately, peginterferon plus ribavirin therapy can be associated ... إقراء المزيد